Disclosed is a topical skin composition and corresponding methods for its use that includes a first MMP-1 inhibitor, wherein said first inhibitor is an extract from Burretiodendron hsienmu, a second MMP-1 inhibitor, wherein said second inhibitor is an extract from Bauhinia brachycarpa var. cavaleriei, and a third MMP-1 inhibitor, wherein said third inhibitor is an extract from Tetracentron sinense.제 1 MMP-1 억제제(상기 제 1 억제제는 Burretiodendron hsienmu의 추출물이다), 제 2 MMP-1 억제제(상기 제 2 억제제는 Bauhinia brachycarpa var. cavaleriei의 추출물이다); 제 3 MMP-1 억제제(상기 제 3 억제제는 Tetracentron sinense의 추출물이다)를 포함하는, 국소 피부 조성물을 제공한다.